SODIUM CHLORIDE TABLETS

SODIUM CHLORIDE TABLETS was reported 75829 times

SODIUM CHLORIDE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 118 0.3894
1 ANTACID THERAPY 48 0.3692
2 DEVICE WIRELESS COMMUNICATION ISSUE 87 0.3359
3 SLEEP DISORDER THERAPY 57 0.2879
4 DEAFNESS PERMANENT 53 0.2704
5 DEVICE MAINTENANCE ISSUE 129 0.2194
6 INFUSION SITE DISCHARGE 313 0.1783
7 GRANULOCYTE COUNT DECREASED 323 0.1740
8 WOUND INFECTION PSEUDOMONAS 53 0.1693
9 ANALGESIC THERAPY 54 0.1682
10 MYELOSUPPRESSION 5526 0.1533
11 DRUG THERAPY 51 0.1504
12 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 785 0.1441
13 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 120 0.1344
14 EJECTION FRACTION 77 0.1325
15 OSMOTIC DEMYELINATION SYNDROME 95 0.1287
16 SENSITISATION 97 0.1278
17 DEVICE INFUSION ISSUE 311 0.1253
18 APPENDICOLITH 48 0.1240
19 INFUSION SITE HAEMORRHAGE 394 0.1196
20 INFUSION SITE IRRITATION 147 0.1144
21 INFUSION SITE DISCOMFORT 111 0.1070
22 ENDOCRINE OPHTHALMOPATHY 85 0.0979
23 CYSTIC FIBROSIS 531 0.0958
24 INFUSION SITE SWELLING 603 0.0957
25 INFUSION SITE PAIN 1224 0.0949
26 INFUSION SITE DISCOLOURATION 83 0.0943
27 INTERLEUKIN LEVEL INCREASED 52 0.0942
28 INFUSION SITE INDURATION 138 0.0931
29 INFUSION SITE WARMTH 114 0.0930
30 INFUSION SITE MASS 100 0.0920
31 ACIDOSIS HYPERCHLORAEMIC 54 0.0909
32 INFUSION SITE INFLAMMATION 64 0.0907
33 INFUSION SITE ERYTHEMA 762 0.0903
34 INFUSION SITE INFECTION 202 0.0868
35 INFUSION SITE PRURITUS 271 0.0858
36 INFUSION SITE BRUISING 173 0.0800
37 INFUSION SITE RASH 109 0.0794
38 HEREDITARY ANGIOEDEMA 844 0.0786
39 FEMALE GENITAL TRACT FISTULA 128 0.0749
40 INCORRECT PRODUCT FORMULATION ADMINISTERED 63 0.0712
41 BLOOD FIBRINOGEN DECREASED 76 0.0665
42 CHRONIC SINUSITIS 242 0.0644
43 CATHETER SITE SWELLING 60 0.0641
44 INFUSION SITE NODULE 61 0.0635
45 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 58 0.0626
46 HYPERPYREXIA 261 0.0616
47 POLYCYSTIC OVARIES 95 0.0612
48 INCORRECT DRUG ADMINISTRATION RATE 250 0.0587
49 VASCULAR DEVICE INFECTION 266 0.0586
50 INFUSION SITE REACTION 173 0.0579
51 DISORGANISED SPEECH 101 0.0547
52 SPUTUM INCREASED 118 0.0545
53 EJECTION FRACTION ABNORMAL 65 0.0530
54 HYPERPHOSPHATAEMIA 112 0.0520
55 CATHETER SITE DISCHARGE 57 0.0507
56 INFUSION SITE EXTRAVASATION 312 0.0501
57 OBSTRUCTIVE SLEEP APNOEA SYNDROME 73 0.0500
58 RADICULOPATHY 131 0.0497
59 CATHETER SITE PAIN 126 0.0485
60 OVARIAN HYPERSTIMULATION SYNDROME 113 0.0484
61 CATHETER SITE ERYTHEMA 98 0.0458
62 PROCTITIS 128 0.0456
63 POOR VENOUS ACCESS 472 0.0456
64 ARTERIAL HAEMORRHAGE 52 0.0455
65 DEVICE ALARM ISSUE 81 0.0446
66 INSURANCE ISSUE 666 0.0435
67 MACULAR DEGENERATION 510 0.0427
68 DERMATITIS CONTACT 473 0.0414
69 HYPERNATRAEMIA 205 0.0411
70 NEUTROPHIL COUNT DECREASED 1666 0.0408
71 HYPERVOLAEMIA 202 0.0408
72 SEROMA 51 0.0401
73 MULTIPLE ALLERGIES 305 0.0389
74 TACHYPNOEA 523 0.0384
75 VEIN RUPTURE 63 0.0376
76 CATHETER SITE HAEMORRHAGE 94 0.0375
77 TEMPERATURE INTOLERANCE 384 0.0372
78 PULMONARY FUNCTION TEST DECREASED 156 0.0356
79 RHINOVIRUS INFECTION 138 0.0354
80 SEASONAL ALLERGY 500 0.0353
81 BODY TEMPERATURE ABNORMAL 65 0.0353
82 DEVICE POWER SOURCE ISSUE 102 0.0349
83 PNEUMONIA PSEUDOMONAL 52 0.0339
84 HAEMATOLOGICAL INFECTION 78 0.0319
85 CENTRAL VENOUS CATHETERISATION 95 0.0315
86 AORTIC VALVE STENOSIS 56 0.0314
87 RESPIRATORY SYMPTOM 89 0.0313
88 OXYGEN THERAPY 51 0.0310
89 OXYGEN CONSUMPTION INCREASED 71 0.0297
90 HEPATIC FUNCTION ABNORMAL 1063 0.0285
91 DEVICE CONNECTION ISSUE 60 0.0284
92 PRODUCT PACKAGING CONFUSION 68 0.0280
93 RHINITIS ALLERGIC 124 0.0278
94 BLOOD PHOSPHORUS INCREASED 76 0.0278
95 NEPHROGENIC ANAEMIA 127 0.0274
96 WHITE BLOOD CELL COUNT DECREASED 2947 0.0272
97 DEAFNESS NEUROSENSORY 89 0.0270
98 BICYTOPENIA 53 0.0270
99 BREATH SOUNDS ABNORMAL 132 0.0267
100 BLOOD CHLORIDE DECREASED 69 0.0267
101 TRAUMATIC HAEMORRHAGE 50 0.0266
102 OBSTRUCTION 105 0.0263
103 INFUSION RELATED REACTION 1691 0.0255
104 DEVICE RELATED SEPSIS 51 0.0253
105 DISTURBANCE IN SOCIAL BEHAVIOUR 59 0.0250
106 AORTIC ARTERIOSCLEROSIS 64 0.0248
107 RESPIRATORY TRACT INFECTION 645 0.0247
108 GRANULOCYTOPENIA 141 0.0247
109 DYSPHORIA 124 0.0245
110 BRONCHIECTASIS 164 0.0243
111 SKIN ABRASION 115 0.0243
112 CYTOKINE RELEASE SYNDROME 487 0.0243
113 PSEUDOMONAS INFECTION 208 0.0242
114 INCREASED BRONCHIAL SECRETION 62 0.0242
115 OXYGEN SATURATION ABNORMAL 68 0.0239
116 AGRANULOCYTOSIS 440 0.0236
117 HYPERPARATHYROIDISM SECONDARY 59 0.0235
118 PRODUCT DISTRIBUTION ISSUE 214 0.0230
119 RALES 133 0.0229
120 TACHYARRHYTHMIA 57 0.0228
121 MYASTHENIA GRAVIS 183 0.0226
122 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 114 0.0225
123 PLEURITIC PAIN 61 0.0221
124 HAEMOGLOBIN INCREASED 100 0.0219
125 HYPOPHOSPHATAEMIA 152 0.0205
126 RESPIRATORY SYNCYTIAL VIRUS INFECTION 176 0.0202
127 UPPER RESPIRATORY TRACT INFECTION 933 0.0202
128 WOUND DEHISCENCE 68 0.0201
129 MYCOBACTERIUM AVIUM COMPLEX INFECTION 54 0.0201
130 ACUTE RESPIRATORY FAILURE 384 0.0199
131 ORAL CANDIDIASIS 261 0.0198
132 HEPATIC CYST 67 0.0197
133 ENDOTRACHEAL INTUBATION 55 0.0196
134 ANAPHYLACTOID REACTION 80 0.0194
135 FIBRIN D DIMER INCREASED 69 0.0194
136 RESPIRATORY RATE INCREASED 172 0.0194
137 EAR INFECTION 515 0.0193
138 BLOOD CREATININE DECREASED 60 0.0191
139 DIVERTICULUM INTESTINAL 83 0.0190
140 HYPONATRAEMIA 1066 0.0189
141 LUNG TRANSPLANT 67 0.0189
142 BLOOD SODIUM INCREASED 50 0.0185
143 COVID-19 PNEUMONIA 218 0.0184
144 SINUSITIS 1878 0.0183
145 PRODUCTIVE COUGH 873 0.0183
146 TROPONIN INCREASED 137 0.0180
147 SKIN LACERATION 194 0.0178
148 PARAESTHESIA ORAL 257 0.0178
149 PURULENT DISCHARGE 76 0.0178
150 PNEUMONIA FUNGAL 70 0.0177
151 CATHETER SITE INFECTION 67 0.0177
152 HYPOXIA 621 0.0176
153 HYPOVOLAEMIA 103 0.0176
154 OXYGEN SATURATION DECREASED 988 0.0176
155 PARANASAL SINUS DISCOMFORT 66 0.0174
156 GASTROINTESTINAL INFECTION 156 0.0174
157 DEVICE OCCLUSION 244 0.0173
158 STRIDOR 51 0.0173
159 DRUG ERUPTION 307 0.0173
160 LIVER INJURY 425 0.0173
161 ATELECTASIS 167 0.0173
162 WEIGHT FLUCTUATION 180 0.0172
163 SPUTUM DISCOLOURED 163 0.0172
164 POSTOPERATIVE WOUND INFECTION 116 0.0172
165 BLOOD SODIUM DECREASED 321 0.0170
166 PHARYNGITIS STREPTOCOCCAL 182 0.0168
167 HYPOKALAEMIA 772 0.0167
168 LARYNGEAL OEDEMA 103 0.0167
169 PNEUMONIA VIRAL 53 0.0166
170 HAEMARTHROSIS 148 0.0165
171 TOXIC EPIDERMAL NECROLYSIS 249 0.0164
172 PRODUCT LEAKAGE 92 0.0164
173 PNEUMONIA BACTERIAL 150 0.0163
174 PRODUCT PREPARATION ISSUE 107 0.0163
175 GASTROENTERITIS VIRAL 294 0.0163
176 CHEST DISCOMFORT 1665 0.0162
177 BACTERAEMIA 192 0.0162
178 SINUS CONGESTION 218 0.0161
179 BONE MARROW FAILURE 327 0.0161
180 BRAIN HERNIATION 48 0.0161
181 HAEMORRHAGE SUBCUTANEOUS 57 0.0161
182 PRODUCT CONTAMINATION 57 0.0160
183 IRON DEFICIENCY 72 0.0160
184 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 94 0.0159
185 RESPIRATORY ACIDOSIS 62 0.0158
186 BLOOD URIC ACID INCREASED 91 0.0157
187 LEFT VENTRICULAR DYSFUNCTION 105 0.0157
188 TRANSAMINASES INCREASED 347 0.0156
189 BACTERIAL INFECTION 291 0.0156
190 TENDERNESS 162 0.0155
191 CYTOPENIA 189 0.0154
192 DRUG-INDUCED LIVER INJURY 482 0.0153
193 VENTRICULAR FIBRILLATION 170 0.0153
194 DEVICE RELATED INFECTION 235 0.0153
195 BLOOD ALBUMIN DECREASED 121 0.0152
196 MENINGITIS ASEPTIC 68 0.0151
197 FULL BLOOD COUNT ABNORMAL 160 0.0151
198 LYMPHOCYTE COUNT DECREASED 264 0.0149
199 AORTIC STENOSIS 52 0.0149
200 BLOOD TEST ABNORMAL 209 0.0149
201 EXTRAVASATION 61 0.0148
202 SKIN INFECTION 166 0.0148
203 LYME DISEASE 49 0.0147
204 CHILLS 1720 0.0147
205 EAR PRURITUS 51 0.0145
206 CYANOSIS 228 0.0145
207 ELECTROLYTE IMBALANCE 168 0.0144
208 BODY TEMPERATURE INCREASED 295 0.0144
209 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 55 0.0144
210 VIRAL INFECTION 479 0.0144
211 SUSPECTED OFF LABEL USE 65 0.0144
212 NEUTROPHIL COUNT INCREASED 146 0.0142
213 FAILURE TO THRIVE 74 0.0142
214 BK VIRUS INFECTION 48 0.0142
215 STREPTOCOCCAL INFECTION 79 0.0142
216 HAEMOPTYSIS 395 0.0141
217 NEUTROPENIC SEPSIS 101 0.0141
218 PULMONARY HYPERTENSION 294 0.0141
219 PROTEIN TOTAL DECREASED 53 0.0141
220 TUMOUR LYSIS SYNDROME 123 0.0140
221 RESPIRATORY TRACT CONGESTION 221 0.0139
222 HYPOALBUMINAEMIA 108 0.0139
223 PLATELET COUNT DECREASED 1473 0.0138
224 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 235 0.0137
225 CARDIOGENIC SHOCK 196 0.0136
226 END STAGE RENAL DISEASE 249 0.0136
227 FEBRILE NEUTROPENIA 905 0.0136
228 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 140 0.0136
229 PARANASAL SINUS HYPERSECRETION 52 0.0136
230 LIGAMENT SPRAIN 134 0.0135
231 OLIGURIA 84 0.0135
232 ESCHERICHIA INFECTION 111 0.0135
233 RED CELL DISTRIBUTION WIDTH INCREASED 56 0.0135
234 TRICUSPID VALVE INCOMPETENCE 107 0.0135
235 EYE INFECTION 152 0.0134
236 BLOOD PHOSPHORUS DECREASED 49 0.0134
237 STAPHYLOCOCCAL SEPSIS 66 0.0134
238 HYPOMAGNESAEMIA 186 0.0133
239 FULL BLOOD COUNT DECREASED 269 0.0133
240 URINE OUTPUT DECREASED 115 0.0131
241 MALNUTRITION 146 0.0130
242 MUSCLE HAEMORRHAGE 52 0.0129
243 VAGINAL DISCHARGE 131 0.0129
244 SINUS TACHYCARDIA 183 0.0129
245 DYSPNOEA EXERTIONAL 485 0.0129
246 PAIN IN JAW 363 0.0128
247 PAPULE 90 0.0128
248 FAECALOMA 70 0.0128
249 MOUTH ULCERATION 269 0.0128
250 TOOTH INFECTION 168 0.0127
251 PNEUMOTHORAX 202 0.0127
252 ANAPHYLACTIC SHOCK 327 0.0127
253 PULSE ABSENT 60 0.0126
254 PYREXIA 4328 0.0125
255 ACUTE PULMONARY OEDEMA 70 0.0125
256 HYPOCALCAEMIA 236 0.0125
257 ASPIRATION 136 0.0124
258 MOUTH HAEMORRHAGE 91 0.0124
259 PRODUCT ADMINISTRATION INTERRUPTED 96 0.0122
260 BENIGN PROSTATIC HYPERPLASIA 63 0.0122
261 BRAIN OEDEMA 153 0.0121
262 PULMONARY ARTERIAL HYPERTENSION 174 0.0120
263 VEIN DISORDER 60 0.0120
264 HYPERCALCAEMIA 148 0.0120
265 PALLOR 325 0.0119
266 CANDIDA INFECTION 201 0.0119
267 PNEUMONIA ASPIRATION 297 0.0119
268 BLOOD PRESSURE SYSTOLIC DECREASED 54 0.0119
269 HYPERLIPIDAEMIA 141 0.0118
270 FOOD POISONING 63 0.0118
271 GROIN PAIN 103 0.0117
272 PROTHROMBIN TIME PROLONGED 70 0.0117
273 SEPSIS 1304 0.0117
274 LOCALISED OEDEMA 54 0.0117
275 BRONCHITIS 863 0.0116
276 DECUBITUS ULCER 95 0.0116
277 SINUS DISORDER 229 0.0116
278 RENAL TUBULAR NECROSIS 113 0.0115
279 INFLAMMATORY MARKER INCREASED 57 0.0115
280 TOXIC ENCEPHALOPATHY 58 0.0114
281 APPENDICITIS 106 0.0113
282 BLOOD CALCIUM DECREASED 127 0.0113
283 STAPHYLOCOCCAL BACTERAEMIA 49 0.0113
284 OROPHARYNGEAL DISCOMFORT 101 0.0112
285 SECRETION DISCHARGE 140 0.0112
286 DISEASE COMPLICATION 51 0.0111
287 BLOOD MAGNESIUM DECREASED 96 0.0111
288 BLOOD UREA INCREASED 186 0.0111
289 ENTEROCOLITIS 64 0.0111
290 COVID-19 1939 0.0110
291 SMALL INTESTINAL OBSTRUCTION 136 0.0110
292 SKIN WARM 64 0.0110
293 COAGULOPATHY 183 0.0110
294 EPILEPSY 334 0.0109
295 APLASTIC ANAEMIA 57 0.0109
296 ILLNESS 1121 0.0109
297 RESPIRATORY FAILURE 791 0.0108
298 BLOOD CREATINE INCREASED 48 0.0108
299 FOOD ALLERGY 83 0.0107
300 BLOOD PRESSURE ABNORMAL 213 0.0107
301 UPPER-AIRWAY COUGH SYNDROME 88 0.0107
302 ASPARTATE AMINOTRANSFERASE INCREASED 566 0.0106
303 PNEUMONIA 3446 0.0106
304 PROCEDURAL PAIN 295 0.0106
305 PROCTALGIA 68 0.0106
306 ARTHROPOD BITE 78 0.0105
307 MITRAL VALVE INCOMPETENCE 119 0.0105
308 CARPAL TUNNEL SYNDROME 147 0.0105
309 DERMATITIS ALLERGIC 132 0.0105
310 DEVICE PHYSICAL PROPERTY ISSUE 80 0.0104
311 BLOOD BILIRUBIN INCREASED 282 0.0104
312 LUNG INFECTION 162 0.0104
313 MULTIPLE ORGAN DYSFUNCTION SYNDROME 295 0.0104
314 ASCITES 306 0.0104
315 COMPLICATION ASSOCIATED WITH DEVICE 151 0.0104
316 KIDNEY INFECTION 203 0.0103
317 DELIRIUM 359 0.0103
318 GENERALISED OEDEMA 128 0.0103
319 ABDOMINAL TENDERNESS 51 0.0103
320 URINARY TRACT INFECTION 1749 0.0102
321 STAPHYLOCOCCAL INFECTION 338 0.0102
322 RESPIRATORY DISTRESS 282 0.0102
323 ECCHYMOSIS 70 0.0102
324 COLITIS 387 0.0102
325 ACIDOSIS 78 0.0102
326 MENINGITIS 68 0.0102
327 EAR DISCOMFORT 104 0.0101
328 NEURALGIA 246 0.0101
329 PULMONARY CONGESTION 133 0.0101
330 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 171 0.0101
331 SLEEP APNOEA SYNDROME 192 0.0101
332 HEART RATE ABNORMAL 56 0.0100
333 HIATUS HERNIA 130 0.0100
334 UNRESPONSIVE TO STIMULI 259 0.0100
335 ANURIA 86 0.0100
336 UROSEPSIS 92 0.0100
337 POST PROCEDURAL INFECTION 81 0.0100
338 BLOOD PRESSURE DECREASED 661 0.0099
339 LIMB INJURY 270 0.0099
340 BLOOD CALCIUM INCREASED 87 0.0099
341 HICCUPS 81 0.0099
342 RIGHT VENTRICULAR FAILURE 69 0.0098
343 SEPTIC SHOCK 427 0.0098
344 ACUTE KIDNEY INJURY 1501 0.0098
345 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 511 0.0098
346 LEUKOCYTOSIS 177 0.0098
347 PHLEBITIS 50 0.0098
348 SENSITIVE SKIN 72 0.0097
349 JOINT INJURY 208 0.0097
350 WHEEZING 576 0.0097
351 RHINITIS 78 0.0097
352 GINGIVAL BLEEDING 132 0.0097
353 DEVICE FAILURE 147 0.0096
354 RESPIRATION ABNORMAL 66 0.0096
355 INFECTION 1386 0.0096
356 CONCOMITANT DISEASE AGGRAVATED 59 0.0096
357 ADRENAL INSUFFICIENCY 116 0.0095
358 PULMONARY MASS 142 0.0095
359 NASAL CONGESTION 560 0.0095
360 RED BLOOD CELL COUNT DECREASED 272 0.0095
361 INFLUENZA 1055 0.0095
362 COUGH 2652 0.0094
363 HYPERKALAEMIA 331 0.0094
364 ALANINE AMINOTRANSFERASE INCREASED 578 0.0094
365 APPETITE DISORDER 62 0.0093
366 BLOOD PRESSURE DIASTOLIC DECREASED 69 0.0093
367 ASPERGILLUS INFECTION 61 0.0093
368 SUPRAVENTRICULAR TACHYCARDIA 88 0.0092
369 MUSCLE STRAIN 79 0.0091
370 BLOOD LACTIC ACID INCREASED 48 0.0091
371 NEPHROPATHY TOXIC 102 0.0091
372 HAEMATOCRIT DECREASED 180 0.0091
373 FLANK PAIN 85 0.0091
374 WOUND INFECTION 99 0.0090
375 TACHYCARDIA 803 0.0090
376 HYPOTENSION 1812 0.0090
377 ATRIAL FLUTTER 72 0.0090
378 FLUSHING 917 0.0090
379 LOWER RESPIRATORY TRACT INFECTION 409 0.0090
380 CLOSTRIDIUM DIFFICILE COLITIS 95 0.0090
381 UPPER GASTROINTESTINAL HAEMORRHAGE 150 0.0089
382 EAR PAIN 173 0.0089
383 DISSEMINATED INTRAVASCULAR COAGULATION 125 0.0089
384 PLEURAL EFFUSION 537 0.0088
385 BRAIN FOG 138 0.0088
386 ENCEPHALOPATHY 215 0.0087
387 BLOOD POTASSIUM DECREASED 263 0.0087
388 TOOTH ABSCESS 89 0.0087
389 LUNG INFILTRATION 77 0.0087
390 SCOLIOSIS 54 0.0087
391 CELLULITIS 439 0.0087
392 CARDIAC FAILURE ACUTE 58 0.0087
393 HAEMATURIA 298 0.0087
394 RASH ERYTHEMATOUS 416 0.0087
395 PULMONARY HAEMORRHAGE 68 0.0087
396 ERYTHEMA MULTIFORME 81 0.0087
397 HYDRONEPHROSIS 65 0.0087
398 PHARYNGITIS 107 0.0086
399 HAEMOGLOBIN DECREASED 885 0.0086
400 BLOOD ALKALINE PHOSPHATASE INCREASED 214 0.0086
401 ABDOMINAL DISTENSION 899 0.0086
402 JOINT DISLOCATION 91 0.0086
403 LOCALISED INFECTION 208 0.0086
404 MUSCULOSKELETAL CHEST PAIN 133 0.0086
405 SINUS HEADACHE 51 0.0086
406 IRON DEFICIENCY ANAEMIA 79 0.0085
407 PULMONARY OEDEMA 383 0.0085
408 LUNG DISORDER 419 0.0085
409 POST PROCEDURAL COMPLICATION 164 0.0085
410 COLD SWEAT 150 0.0085
411 MICTURITION URGENCY 97 0.0085
412 PERICARDIAL EFFUSION 196 0.0085
413 ANAL INCONTINENCE 76 0.0084
414 DYSPNOEA 4775 0.0084
415 IMPAIRED QUALITY OF LIFE 121 0.0084
416 GOUT 151 0.0084
417 FUNGAL INFECTION 280 0.0084
418 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 63 0.0084
419 CYSTITIS 267 0.0084
420 RESPIRATORY DISORDER 250 0.0083
421 METABOLIC ACIDOSIS 267 0.0083
422 PANCYTOPENIA 466 0.0083
423 HEART RATE INCREASED 826 0.0083
424 OEDEMA 452 0.0083
425 BODY TEMPERATURE DECREASED 82 0.0083
426 FREQUENT BOWEL MOVEMENTS 225 0.0083
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1494 0.0083
428 VOMITING 3888 0.0083
429 CONCUSSION 64 0.0083
430 NASOPHARYNGITIS 1522 0.0082
431 CONJUNCTIVITIS 153 0.0082
432 ANAPHYLACTIC REACTION 450 0.0081
433 EPISTAXIS 609 0.0081
434 WRONG PRODUCT ADMINISTERED 55 0.0081
435 ANAEMIA 1550 0.0081
436 LEUKOPENIA 406 0.0081
437 OEDEMA PERIPHERAL 982 0.0080
438 HYPOTHYROIDISM 257 0.0080
439 ILEUS 100 0.0080
440 HAND FRACTURE 57 0.0080
441 CIRCULATORY COLLAPSE 137 0.0080
442 ELECTROCARDIOGRAM ABNORMAL 63 0.0080
443 HEAD INJURY 252 0.0080
444 CLOSTRIDIUM DIFFICILE INFECTION 173 0.0079
445 RASH MACULO-PAPULAR 176 0.0079
446 PHARYNGEAL SWELLING 77 0.0079
447 THROAT IRRITATION 353 0.0079
448 PETECHIAE 82 0.0079
449 ULCER 125 0.0078
450 MENTAL STATUS CHANGES 218 0.0078
451 DIZZINESS POSTURAL 76 0.0078
452 PNEUMONITIS 213 0.0078
453 PRODUCT ADMINISTRATION ERROR 158 0.0078
454 GASTROOESOPHAGEAL REFLUX DISEASE 629 0.0078
455 SWELLING OF EYELID 49 0.0078
456 VITAMIN D DEFICIENCY 76 0.0078
457 PERIPHERAL COLDNESS 107 0.0078
458 DEHYDRATION 1039 0.0078
459 HAEMOGLOBIN ABNORMAL 50 0.0078
460 BLOOD CREATININE INCREASED 507 0.0078
461 HYPERTRANSAMINASAEMIA 54 0.0078
462 BRONCHOSPASM 110 0.0077
463 C-REACTIVE PROTEIN INCREASED 280 0.0077
464 OROPHARYNGEAL PAIN 711 0.0077
465 VENTRICULAR TACHYCARDIA 126 0.0076
466 EMBOLISM 63 0.0076
467 PRODUCT USE COMPLAINT 119 0.0075
468 FEELING COLD 210 0.0075
469 FOOT FRACTURE 143 0.0075
470 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
471 HYPERGLYCAEMIA 272 0.0075
472 RETCHING 159 0.0075
473 FLUID RETENTION 379 0.0074
474 POLYURIA 61 0.0074
475 ABNORMAL FAECES 61 0.0074
476 EOSINOPHIL COUNT INCREASED 62 0.0074
477 DECREASED APPETITE 1726 0.0074
478 CARDIOTOXICITY 66 0.0074
479 ABDOMINAL PAIN 1718 0.0074
480 STEVENS-JOHNSON SYNDROME 164 0.0074
481 OBSTRUCTIVE AIRWAYS DISORDER 82 0.0074
482 GASTROINTESTINAL DISORDER 660 0.0074
483 SCAB 84 0.0074
484 RHINORRHOEA 476 0.0074
485 INTERNAL HAEMORRHAGE 84 0.0073
486 MYOCARDITIS 84 0.0073
487 HEPATOMEGALY 72 0.0073
488 OSTEOPENIA 111 0.0073
489 FLUID OVERLOAD 106 0.0073
490 BRAIN INJURY 73 0.0073
491 HAEMATOMA 188 0.0072
492 SINUS BRADYCARDIA 70 0.0072
493 HYPERBILIRUBINAEMIA 75 0.0072
494 PRODUCT DOSE OMISSION ISSUE 2128 0.0072
495 ASPHYXIA 59 0.0072
496 GAMMA-GLUTAMYLTRANSFERASE INCREASED 160 0.0072
497 HAEMODYNAMIC INSTABILITY 55 0.0072
498 BLOOD PRESSURE INCREASED 1103 0.0072
499 NEPHROPATHY 67 0.0072
500 THROMBOCYTOPENIA 802 0.0072
501 INTENTIONAL DOSE OMISSION 204 0.0071
502 EMPHYSEMA 72 0.0071
503 HEPATIC FAILURE 215 0.0071
504 HEART RATE DECREASED 249 0.0071
505 WHITE BLOOD CELL COUNT INCREASED 272 0.0071
506 UNINTENTIONAL MEDICAL DEVICE REMOVAL 82 0.0071
507 MIGRAINE 674 0.0071
508 THERAPY NON-RESPONDER 317 0.0070
509 WEIGHT DECREASED 1968 0.0070
510 HEADACHE 4416 0.0070
511 WRIST FRACTURE 84 0.0070
512 HYPOPHAGIA 179 0.0070
513 THERAPY PARTIAL RESPONDER 109 0.0070
514 SPINAL OSTEOARTHRITIS 61 0.0069
515 PRESYNCOPE 168 0.0069
516 SEIZURE 798 0.0069
517 LOWER GASTROINTESTINAL HAEMORRHAGE 51 0.0069
518 BLOOD POTASSIUM INCREASED 112 0.0069
519 HOSPICE CARE 68 0.0069
520 NAUSEA 5445 0.0069
521 HOSPITALISATION 1056 0.0069
522 NEPHROLITHIASIS 315 0.0069
523 HYPERCHOLESTEROLAEMIA 66 0.0068
524 RECTAL HAEMORRHAGE 293 0.0068
525 HAEMORRHOIDS 133 0.0068
526 APNOEA 53 0.0068
527 THROAT TIGHTNESS 184 0.0068
528 AUTOIMMUNE DISORDER 66 0.0068
529 ERUCTATION 131 0.0068
530 SENSATION OF FOREIGN BODY 57 0.0068
531 HAEMATOCHEZIA 372 0.0067
532 DISCOMFORT 410 0.0067
533 DYSURIA 247 0.0067
534 EYELID OEDEMA 78 0.0067
535 FEEDING DISORDER 136 0.0067
536 DYSPEPSIA 659 0.0067
537 CARDIAC ARREST 552 0.0067
538 CARDIOMEGALY 82 0.0067
539 FIBROMYALGIA 162 0.0067
540 SARS-COV-2 TEST POSITIVE 88 0.0067
541 CONTUSION 641 0.0067
542 URINARY RETENTION 222 0.0066
543 TORSADE DE POINTES 52 0.0066
544 INITIAL INSOMNIA 68 0.0066
545 CHEST PAIN 1227 0.0066
546 PRODUCT PREPARATION ERROR 136 0.0066
547 BACK PAIN 1528 0.0066
548 DIVERTICULITIS 182 0.0066
549 TUBULOINTERSTITIAL NEPHRITIS 123 0.0066
550 PROCEDURAL COMPLICATION 50 0.0065
551 NEUROTOXICITY 114 0.0065
552 HYPOAESTHESIA ORAL 98 0.0065
553 HYPERTENSION 1377 0.0065
554 ATRIAL FIBRILLATION 633 0.0065
555 RIB FRACTURE 133 0.0065
556 APHONIA 90 0.0064
557 DYSPHAGIA 611 0.0064
558 FACE OEDEMA 108 0.0064
559 BRADYCARDIA 338 0.0064
560 CHRONIC KIDNEY DISEASE 483 0.0064
561 INABILITY TO AFFORD MEDICATION 63 0.0063
562 INCONTINENCE 67 0.0063
563 BLOOD IRON DECREASED 75 0.0063
564 ASTHMA 714 0.0063
565 INTENTIONAL PRODUCT USE ISSUE 552 0.0063
566 RENAL CYST 50 0.0063
567 MUSCULOSKELETAL DISCOMFORT 108 0.0063
568 SYNCOPE 627 0.0063
569 DEVICE DISLOCATION 272 0.0062
570 ASTHENIA 2349 0.0062
571 PURPURA 55 0.0062
572 CHOLECYSTITIS 74 0.0062
573 DRY THROAT 63 0.0062
574 GASTROENTERITIS 90 0.0062
575 PSYCHOLOGICAL TRAUMA 53 0.0061
576 BLOOD LACTATE DEHYDROGENASE INCREASED 97 0.0061
577 NECK PAIN 342 0.0061
578 PYELONEPHRITIS 53 0.0061
579 TRANSFUSION 64 0.0061
580 ERYTHEMA 1252 0.0061
581 PULMONARY EMBOLISM 576 0.0061
582 PRESCRIBED OVERDOSE 117 0.0060
583 SHOCK 139 0.0060
584 PALPITATIONS 706 0.0060
585 ABSCESS 96 0.0060
586 BLOOD PRESSURE SYSTOLIC INCREASED 117 0.0060
587 PNEUMOCYSTIS JIROVECII PNEUMONIA 60 0.0060
588 VITAMIN D DECREASED 51 0.0060
589 POST PROCEDURAL HAEMORRHAGE 69 0.0059
590 MUCOSAL INFLAMMATION 155 0.0059
591 FALL 1961 0.0059
592 SUBARACHNOID HAEMORRHAGE 60 0.0059
593 PRODUCT USE ISSUE 1107 0.0059
594 RASH PRURITIC 319 0.0059
595 ECONOMIC PROBLEM 89 0.0059
596 CARDIOVASCULAR DISORDER 149 0.0059
597 SWELLING 549 0.0059
598 TASTE DISORDER 119 0.0059
599 DYSPHONIA 343 0.0059
600 ORTHOSTATIC HYPOTENSION 102 0.0059
601 DIARRHOEA 3774 0.0058
602 LETHARGY 336 0.0058
603 HAEMATEMESIS 148 0.0058
604 ALTERED STATE OF CONSCIOUSNESS 126 0.0058
605 HEPATIC ENZYME INCREASED 396 0.0058
606 MOTOR DYSFUNCTION 59 0.0058
607 MENTAL DISORDER 251 0.0058
608 OESOPHAGITIS 63 0.0058
609 RENAL FAILURE 763 0.0057
610 ACUTE RESPIRATORY DISTRESS SYNDROME 101 0.0057
611 HYPOTONIA 57 0.0057
612 GASTRITIS 150 0.0057
613 CONSTIPATION 1242 0.0057
614 CARDIOMYOPATHY 84 0.0057
615 VENTRICULAR EXTRASYSTOLES 59 0.0057
616 CORONARY ARTERY DISEASE 172 0.0057
617 HERPES ZOSTER 326 0.0057
618 UPPER LIMB FRACTURE 113 0.0057
619 POOR QUALITY SLEEP 122 0.0057
620 PRODUCT AVAILABILITY ISSUE 129 0.0057
621 FEELING HOT 347 0.0057
622 GENERAL PHYSICAL HEALTH DETERIORATION 653 0.0056
623 NEUTROPENIA 767 0.0056
624 RASH PAPULAR 126 0.0056
625 RENAL IMPAIRMENT 472 0.0056
626 PERIPHERAL SWELLING 865 0.0056
627 GASTROINTESTINAL HAEMORRHAGE 469 0.0056
628 MULTI-ORGAN FAILURE 97 0.0056
629 EYELID PTOSIS 57 0.0056
630 PRURITUS 2154 0.0056
631 IMPAIRED GASTRIC EMPTYING 76 0.0056
632 MYOSITIS 50 0.0056
633 TINNITUS 256 0.0056
634 DRUG LEVEL INCREASED 92 0.0056
635 SCAR 95 0.0055
636 URINARY INCONTINENCE 164 0.0055
637 PRODUCT USE IN UNAPPROVED INDICATION 1371 0.0055
638 ARTERIOSCLEROSIS 52 0.0055
639 MUSCULAR WEAKNESS 625 0.0055
640 GENERALISED TONIC-CLONIC SEIZURE 91 0.0055
641 LIVER FUNCTION TEST INCREASED 118 0.0055
642 SLEEP DISORDER 387 0.0055
643 MYELODYSPLASTIC SYNDROME 79 0.0055
644 GLOMERULAR FILTRATION RATE DECREASED 67 0.0054
645 PLATELET COUNT INCREASED 71 0.0054
646 RESPIRATORY ARREST 150 0.0054
647 SNEEZING 122 0.0054
648 FATIGUE 4226 0.0054
649 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 386 0.0054
650 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 260 0.0054
651 RESTLESSNESS 198 0.0054
652 SCRATCH 57 0.0054
653 THROMBOSIS 433 0.0054
654 OFF LABEL USE 4708 0.0054
655 ACCIDENT 64 0.0054
656 HEPATIC ENCEPHALOPATHY 50 0.0054
657 INTERSTITIAL LUNG DISEASE 259 0.0053
658 EJECTION FRACTION DECREASED 83 0.0053
659 ABDOMINAL PAIN LOWER 135 0.0053
660 HYPERSOMNIA 153 0.0053
661 INTESTINAL OBSTRUCTION 201 0.0053
662 RENAL DISORDER 247 0.0053
663 CYTOMEGALOVIRUS INFECTION 88 0.0053
664 MUSCLE ATROPHY 67 0.0053
665 HAEMORRHAGE INTRACRANIAL 79 0.0053
666 HAEMORRHAGE 551 0.0053
667 CARDIAC FAILURE 422 0.0053
668 OSTEOMYELITIS 95 0.0052
669 PULMONARY THROMBOSIS 57 0.0052
670 LYMPHADENOPATHY 185 0.0052
671 SPLENOMEGALY 61 0.0052
672 CEREBRAL INFARCTION 127 0.0052
673 HERNIA 100 0.0052
674 URTICARIA 861 0.0051
675 LIMB DISCOMFORT 159 0.0051
676 ORAL HERPES 100 0.0051
677 SWELLING FACE 331 0.0051
678 FAECES DISCOLOURED 110 0.0051
679 DEVICE ISSUE 455 0.0051
680 WEIGHT INCREASED 1132 0.0050
681 HYPERHIDROSIS 651 0.0050
682 TREMOR 836 0.0050
683 MASS 70 0.0050
684 ACUTE MYELOID LEUKAEMIA 78 0.0050
685 THERAPY INTERRUPTED 357 0.0050
686 OCULAR DISCOMFORT 56 0.0050
687 DEVICE LEAKAGE 216 0.0050
688 DIZZINESS 2482 0.0050
689 AGITATION 365 0.0050
690 BURNING SENSATION 348 0.0050
691 APHASIA 149 0.0049
692 MUSCLE RIGIDITY 59 0.0049
693 HYPERSENSITIVITY 914 0.0049
694 MALAISE 2156 0.0049
695 LOSS OF CONSCIOUSNESS 629 0.0049
696 IMMUNODEFICIENCY 73 0.0049
697 LIP SWELLING 163 0.0049
698 RASH 2133 0.0049
699 DEEP VEIN THROMBOSIS 317 0.0049
700 LACRIMATION INCREASED 147 0.0049
701 CHOLELITHIASIS 159 0.0048
702 EATING DISORDER 103 0.0048
703 PAIN 2969 0.0048
704 BLISTER 271 0.0048
705 ORAL PAIN 108 0.0048
706 NEUROPATHY PERIPHERAL 457 0.0048
707 TRANSIENT ISCHAEMIC ATTACK 162 0.0048
708 INTERNATIONAL NORMALISED RATIO INCREASED 136 0.0048
709 HYPERTHYROIDISM 69 0.0048
710 STOMATITIS 289 0.0048
711 WOUND 133 0.0048
712 CEREBRAL HAEMORRHAGE 170 0.0047
713 PROTEINURIA 90 0.0047
714 PAIN IN EXTREMITY 1392 0.0047
715 TOOTH FRACTURE 52 0.0047
716 RENAL PAIN 50 0.0047
717 DIPLOPIA 122 0.0047
718 SPINAL PAIN 55 0.0047
719 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 109 0.0047
720 HEPATIC STEATOSIS 87 0.0047
721 COLITIS ULCERATIVE 208 0.0046
722 INFLUENZA LIKE ILLNESS 383 0.0046
723 DEPRESSED LEVEL OF CONSCIOUSNESS 184 0.0046
724 MUSCLE TWITCHING 107 0.0046
725 BLOOD URINE PRESENT 88 0.0046
726 DECREASED ACTIVITY 50 0.0046
727 MELAENA 102 0.0046
728 RASH MACULAR 162 0.0046
729 CONFUSIONAL STATE 748 0.0046
730 ELECTROCARDIOGRAM QT PROLONGED 166 0.0046
731 MYOCLONUS 55 0.0046
732 HEART RATE IRREGULAR 104 0.0046
733 HYPOAESTHESIA 687 0.0046
734 PHOTOPHOBIA 86 0.0046
735 MYOCARDIAL ISCHAEMIA 52 0.0046
736 BLOOD PRESSURE FLUCTUATION 109 0.0045
737 NOCTURIA 55 0.0045
738 DISORIENTATION 178 0.0045
739 ABDOMINAL DISCOMFORT 745 0.0044
740 BACK DISORDER 72 0.0044
741 CONDITION AGGRAVATED 1345 0.0044
742 ARRHYTHMIA 209 0.0044
743 DYSARTHRIA 166 0.0044
744 HALLUCINATION 332 0.0044
745 PANCREATITIS ACUTE 99 0.0044
746 RESTLESS LEGS SYNDROME 80 0.0044
747 RENAL INJURY 130 0.0044
748 CARDIO-RESPIRATORY ARREST 183 0.0044
749 MYDRIASIS 56 0.0044
750 THYROID DISORDER 67 0.0043
751 INTERVERTEBRAL DISC PROTRUSION 95 0.0043
752 METASTASES TO CENTRAL NERVOUS SYSTEM 56 0.0043
753 ANXIETY 1233 0.0043
754 SCIATICA 69 0.0043
755 RENAL FAILURE ACUTE 183 0.0043
756 EXPOSURE DURING PREGNANCY 268 0.0043
757 ACUTE MYOCARDIAL INFARCTION 127 0.0043
758 CHOKING 84 0.0043
759 HYPOGLYCAEMIA 206 0.0042
760 ROAD TRAFFIC ACCIDENT 176 0.0042
761 METASTASES TO BONE 69 0.0042
762 HIP FRACTURE 135 0.0042
763 SUBDURAL HAEMATOMA 60 0.0042
764 CARDIAC DISORDER 392 0.0042
765 ACUTE HEPATIC FAILURE 57 0.0042
766 SKIN LESION 114 0.0042
767 INCORRECT PRODUCT ADMINISTRATION DURATION 90 0.0042
768 LIVER DISORDER 184 0.0041
769 NODULE 54 0.0041
770 PARALYSIS 59 0.0041
771 DEVICE USE ERROR 143 0.0041
772 SOMNOLENCE 827 0.0041
773 SKIN ULCER 106 0.0041
774 IMMUNE SYSTEM DISORDER 54 0.0041
775 NIGHT SWEATS 132 0.0041
776 PHARYNGEAL OEDEMA 63 0.0041
777 HEMIPARESIS 69 0.0041
778 ANKLE FRACTURE 63 0.0041
779 SPEECH DISORDER 213 0.0041
780 PARANOIA 70 0.0041
781 HEPATIC CIRRHOSIS 76 0.0040
782 HEAD DISCOMFORT 71 0.0040
783 IMPAIRED HEALING 131 0.0040
784 SKIN DISORDER 133 0.0040
785 SPINAL OPERATION 49 0.0040
786 CARDIAC FAILURE CONGESTIVE 319 0.0040
787 LYMPHOPENIA 56 0.0040
788 SKIN DISCOLOURATION 181 0.0039
789 TOOTHACHE 71 0.0039
790 SKIN REACTION 55 0.0039
791 JAUNDICE 105 0.0039
792 PREGNANCY 78 0.0039
793 MALIGNANT NEOPLASM PROGRESSION 396 0.0039
794 BONE PAIN 226 0.0039
795 PULMONARY FIBROSIS 74 0.0039
796 ABDOMINAL PAIN UPPER 794 0.0039
797 BASAL CELL CARCINOMA 60 0.0038
798 PLASMA CELL MYELOMA 150 0.0038
799 MUSCLE TIGHTNESS 62 0.0038
800 GASTRIC ULCER 72 0.0038
801 MUSCLE SPASMS 694 0.0038
802 EYE PAIN 213 0.0038
803 PANCREATITIS 199 0.0038
804 METASTASES TO LIVER 66 0.0038
805 LACTIC ACIDOSIS 121 0.0037
806 PRODUCT PRESCRIBING ISSUE 81 0.0037
807 BLOOD CREATINE PHOSPHOKINASE INCREASED 107 0.0037
808 HALLUCINATION, AUDITORY 59 0.0037
809 OBESITY 59 0.0037
810 DEPRESSED MOOD 195 0.0037
811 BLOOD TRIGLYCERIDES INCREASED 65 0.0037
812 PARAESTHESIA 578 0.0037
813 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
814 SKIN CANCER 79 0.0037
815 TENDONITIS 56 0.0036
816 DISEASE PROGRESSION 426 0.0036
817 ARTHRALGIA 1485 0.0036
818 COMA 170 0.0036
819 DRY MOUTH 288 0.0035
820 NEEDLE ISSUE 103 0.0035
821 RHABDOMYOLYSIS 147 0.0035
822 EYE SWELLING 131 0.0035
823 PHOTOSENSITIVITY REACTION 58 0.0035
824 MATERNAL EXPOSURE DURING PREGNANCY 313 0.0035
825 CATARACT 209 0.0035
826 BALANCE DISORDER 302 0.0035
827 DERMATITIS 73 0.0035
828 VERTIGO 212 0.0035
829 OCULAR HYPERAEMIA 164 0.0035
830 POLLAKIURIA 144 0.0034
831 INFLAMMATION 178 0.0034
832 LIVER FUNCTION TEST ABNORMAL 100 0.0034
833 FEELING ABNORMAL 822 0.0034
834 INJURY 240 0.0034
835 HEPATOTOXICITY 76 0.0034
836 FLATULENCE 193 0.0034
837 SWOLLEN TONGUE 105 0.0034
838 ABNORMAL BEHAVIOUR 133 0.0034
839 ANHEDONIA 88 0.0033
840 DIABETES MELLITUS 255 0.0033
841 MYALGIA 567 0.0033
842 LOWER LIMB FRACTURE 64 0.0033
843 OSTEOPOROSIS 137 0.0033
844 DRY EYE 166 0.0033
845 CHROMATURIA 75 0.0033
846 UNEVALUABLE EVENT 251 0.0033
847 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 182 0.0033
848 DRUG INTOLERANCE 317 0.0033
849 ARTHRITIS 256 0.0033
850 GALLBLADDER DISORDER 58 0.0032
851 NERVOUS SYSTEM DISORDER 101 0.0032
852 LYMPHOMA 50 0.0032
853 TREATMENT NONCOMPLIANCE 175 0.0032
854 TOOTH DISORDER 71 0.0032
855 IRRITABLE BOWEL SYNDROME 68 0.0032
856 AGEUSIA 78 0.0031
857 ILL-DEFINED DISORDER 189 0.0031
858 CRYING 112 0.0031
859 CHOLESTASIS 59 0.0031
860 EYE PRURITUS 103 0.0031
861 IRRITABILITY 184 0.0031
862 DEAFNESS 80 0.0031
863 VISION BLURRED 417 0.0030
864 PREMATURE BABY 91 0.0030
865 GAIT DISTURBANCE 573 0.0030
866 SURGERY 174 0.0030
867 THIRST 53 0.0030
868 DIABETIC KETOACIDOSIS 71 0.0030
869 DYSSTASIA 86 0.0029
870 TYPE 2 DIABETES MELLITUS 99 0.0029
871 GAIT INABILITY 98 0.0029
872 HYPOACUSIS 126 0.0029
873 MUSCULOSKELETAL STIFFNESS 255 0.0029
874 JOINT SWELLING 349 0.0029
875 SPINAL FRACTURE 57 0.0028
876 INSOMNIA 754 0.0028
877 INCREASED APPETITE 54 0.0028
878 PANIC ATTACK 103 0.0028
879 ADVERSE EVENT 260 0.0028
880 OSTEOARTHRITIS 118 0.0028
881 BLOOD CHOLESTEROL INCREASED 129 0.0028
882 ANGIOEDEMA 122 0.0028
883 PELVIC PAIN 50 0.0027
884 EMOTIONAL DISTRESS 332 0.0027
885 UNDERDOSE 200 0.0027
886 MUSCULOSKELETAL PAIN 142 0.0027
887 SYSTEMIC LUPUS ERYTHEMATOSUS 96 0.0027
888 HALLUCINATION, VISUAL 57 0.0027
889 DEVICE MALFUNCTION 188 0.0027
890 DEMENTIA 74 0.0026
891 DRUG INTERACTION 418 0.0026
892 HEPATITIS 67 0.0026
893 SEDATION 68 0.0026
894 HOT FLUSH 195 0.0026
895 BLOOD GLUCOSE DECREASED 124 0.0026
896 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 87 0.0026
897 LABORATORY TEST ABNORMAL 76 0.0026
898 THERAPEUTIC RESPONSE SHORTENED 85 0.0026
899 PERITONITIS 53 0.0026
900 INTENTIONAL PRODUCT MISUSE 223 0.0025
901 ACCIDENTAL OVERDOSE 93 0.0025
902 NEOPLASM PROGRESSION 87 0.0025
903 MOBILITY DECREASED 179 0.0025
904 BLOOD GLUCOSE INCREASED 467 0.0025
905 JOINT STIFFNESS 65 0.0025
906 SKIN EXFOLIATION 208 0.0025
907 COGNITIVE DISORDER 115 0.0025
908 CEREBROVASCULAR ACCIDENT 415 0.0024
909 ANGINA PECTORIS 70 0.0024
910 ECZEMA 126 0.0024
911 PRODUCT PRESCRIBING ERROR 57 0.0024
912 MOOD SWINGS 76 0.0024
913 VISUAL IMPAIRMENT 294 0.0024
914 DYSKINESIA 96 0.0024
915 MEDICATION ERROR 131 0.0024
916 ALOPECIA 458 0.0023
917 DEPRESSION 530 0.0023
918 ADVERSE DRUG REACTION 208 0.0023
919 NEOPLASM MALIGNANT 153 0.0023
920 ARTHROPATHY 126 0.0023
921 DEATH 1951 0.0023
922 EYE DISORDER 74 0.0022
923 DYSGEUSIA 166 0.0022
924 FEAR 60 0.0022
925 INCORRECT DOSE ADMINISTERED 504 0.0022
926 DISTURBANCE IN ATTENTION 119 0.0022
927 MOVEMENT DISORDER 70 0.0022
928 FEMUR FRACTURE 67 0.0022
929 MEMORY IMPAIRMENT 292 0.0021
930 EYE IRRITATION 121 0.0021
931 PSYCHOTIC DISORDER 62 0.0021
932 MOOD ALTERED 57 0.0021
933 TOXICITY TO VARIOUS AGENTS 339 0.0020
934 AMNESIA 129 0.0020
935 INJECTION SITE SWELLING 150 0.0020
936 NO ADVERSE EVENT 354 0.0020
937 NERVOUSNESS 102 0.0020
938 DRY SKIN 260 0.0019
939 EMOTIONAL DISORDER 60 0.0019
940 NIGHTMARE 67 0.0019
941 DRUG INEFFECTIVE 2491 0.0019
942 SKIN IRRITATION 85 0.0019
943 VAGINAL HAEMORRHAGE 80 0.0018
944 MYOCARDIAL INFARCTION 321 0.0018
945 EXTRA DOSE ADMINISTERED 73 0.0018
946 DRUG EFFECT INCOMPLETE 65 0.0018
947 INJECTION SITE RASH 54 0.0018
948 DEVICE BREAKAGE 71 0.0017
949 CONVULSION 100 0.0017
950 OSTEONECROSIS 56 0.0017
951 ANGER 57 0.0017
952 INJECTION SITE PRURITUS 112 0.0017
953 FOETAL EXPOSURE DURING PREGNANCY 133 0.0016
954 DRUG ADMINISTRATION ERROR 50 0.0016
955 INJECTION SITE ERYTHEMA 201 0.0016
956 AGGRESSION 81 0.0016
957 OVERDOSE 343 0.0016
958 DEVICE DIFFICULT TO USE 104 0.0016
959 INJECTION SITE MASS 58 0.0016
960 THERAPY CESSATION 79 0.0015
961 GASTRIC DISORDER 51 0.0015
962 SUICIDAL IDEATION 135 0.0015
963 INJECTION SITE REACTION 97 0.0014
964 PRODUCT DOSE OMISSION 92 0.0014
965 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
966 BLINDNESS 57 0.0014
967 INCORRECT ROUTE OF DRUG ADMINISTRATION 49 0.0014
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 63 0.0013
969 LUNG NEOPLASM MALIGNANT 55 0.0013
970 INJECTION SITE PAIN 401 0.0013
971 DISEASE RECURRENCE 61 0.0013
972 PRODUCT QUALITY ISSUE 172 0.0013
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 256 0.0013
974 ABORTION SPONTANEOUS 50 0.0012
975 INJECTION SITE BRUISING 99 0.0012
976 INJECTION SITE HAEMORRHAGE 99 0.0012
977 THERAPEUTIC RESPONSE DECREASED 75 0.0012
978 INTENTIONAL OVERDOSE 79 0.0012
979 RHEUMATOID ARTHRITIS 138 0.0012
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 82 0.0012
981 MULTIPLE SCLEROSIS 54 0.0011
982 SUICIDE ATTEMPT 61 0.0010
983 TREATMENT FAILURE 81 0.0010
984 ACNE 74 0.0010
985 DRUG ABUSE 81 0.0010
986 PRODUCT STORAGE ERROR 84 0.0010
987 SKIN BURNING SENSATION 68 0.0009
988 BREAST CANCER 86 0.0009
989 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
990 ACCIDENTAL EXPOSURE TO PRODUCT 74 0.0007
991 DRUG DOSE OMISSION 111 0.0007
992 PSORIASIS 80 0.0006